Disease | vogt-koyanagi-harada disease |
Symptom | C0035305|retinal detachment |
Sentences | 2 |
PubMedID- 23903795 | Conclusion: intravitreal injection of bevacizumab during the corticosteroid therapy may be a treatment option for patients with decreased visual function because of persistent serous retinal detachment associated with vogt-koyanagi-harada syndrome. |
PubMedID- 20689964 | Intravitreal bevacizumab injection for persistent serous retinal detachment associated with vogt-koyanagi-harada disease. |
Page: 1